CN106511547A - Medicine for preventing and treating frog disease in America and preparation method of medicine - Google Patents
Medicine for preventing and treating frog disease in America and preparation method of medicine Download PDFInfo
- Publication number
- CN106511547A CN106511547A CN201611110762.2A CN201611110762A CN106511547A CN 106511547 A CN106511547 A CN 106511547A CN 201611110762 A CN201611110762 A CN 201611110762A CN 106511547 A CN106511547 A CN 106511547A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- medicine
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/483—Gleditsia (locust)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for preventing and treating frog disease in America. The medicine is prepared from, by mass, 170-210 parts of rheum officinale, 50-80 parts of concha haliotidis, 190-220 parts of alfalfa, 180-215 parts of milkvetch roots, 180-210 parts of myrrh, 80-110 parts of wormwood, 130-165 parts of salvia chinensis, 185-215 parts of cape jasmine, 105-135 parts of asarum, 105-140 parts of gleditsia officinalis, 135-160 parts of white paeony roots, 120-150 parts of Chinese fevervine herb and roots and 50-70 parts of cassia seeds. According to the medicine, incompatibility of the raw materials in the medicine does not exist, the occurrence rate of frog disease in America can be obviously lowered, a quite good prevention and treatment effect is achieved on frog disease in America, no toxic or side effect is produced, use is safe, and no harmful medicine residue is left.
Description
Technical field
The invention belongs to Rana nigromaculata cultural technique field, and in particular to a kind of protective agents of Rana grylia disease and its preparation
Method.
Background technology
Rana grylia also known as the river frog, Hylarana guentheri.The U.S. is originated in, the later stage eighties 20th century introduces China, its fine and tender taste,
Delicious flavour, is first-class Rana esculenta, has promoted cultivation throughout the country.Rana grylia has that individual big, growth is fast, taste
Delicious, protein content is high, is a kind of high-quality and efficient economic cultivation batrachia.With industry competition fierceness, some old raisers
Cultural technique old stuff, causes to produce effect lowly, and some can't regain one's original capital, and some cultivation are not stinted using some forbidden drugs, cause Rana nigromaculata
Harmful substance accumulation, so as to cause mortality, also makes cultivation water suffer severe contamination in vivo, also ecological around collateral damage
Environment.
In breeding process, large-scale cultivation is susceptible to disease to Rana grylia, and is very easy to spread, mainly
There is following disease:Tadpole period Common Diseases:Disease, septicemia, enteritis, fish moldss, ascites, trichodinasis, gas bubble disease;It is common into the frog
Disease:Enteritis, red leg disease, infectious liver disease, white-eyes-sickness, bark rot etc., by putting into practice, exploring, Experimental comparison, take to prevent
Based on.
Wherein Rana grylia torticollis disease is that the bacterium directly destroys the cranial nerve of the frog by caused by meningitiss deteriorated blood Flavobacterium,
Cause mentally deranged generation torticollis.The ill frog is ceaselessly spinned in water, askew turn to the left or to the right of its head.Sick frog food ration subtracts
Few, mortality rate is high, if processing the sick frog not in time, it will infect frog group.Main infection mode has two kinds, and one is directly from parent
To filial generation, two is mutually infection.
Rana grylia disease is prevented and treated using Western medicine typically in prior art, drug dependence is easily caused, or is affected Rana nigromaculata
Meat, it is therefore necessary to develop a kind of protective agents of Rana grylia disease.
The content of the invention
It is an object of the invention to overcome the deficiencies in the prior art, there is provided a kind of protective agents of Rana grylia disease, medicine
In thing there is no incompatibility in each material combination, can substantially reduce the incidence rate of Rana grylia disease, Rana grylia disease is had
Good preventive and therapeutic action, and have no toxic side effect, using safety, remain without hazardous drugs.
The technical solution adopted for the present invention to solve the technical problems is:
The technical scheme is that:A kind of protective agents of Rana grylia disease, which is by the raw material of following masses part proportioning
Medicine is made:Radix Et Rhizoma Rhei 170-210 parts, Concha Haliotidis 50-80 parts, toothed burclover 190-220 parts, Radix Astragali 180-215 parts, Myrrha 180-210 parts,
Folium Artemisiae Argyi 80-110 parts, Herba Salviae Chinensiss 130-165 parts, Fructus Gardeniae 185-215 parts, Herba Asari 105-135 parts, Fructus Gleditsiae Abnormalis 105-140 parts, Radix Paeoniae Alba 135-
160 parts, Herba Paederiae 120-150 parts, Semen Cassiae 50-70 parts.
Its further preferred mass part proportioning is:Radix Et Rhizoma Rhei 170-205 parts, Concha Haliotidis 50-75 parts, toothed burclover 190-215 parts,
Radix Astragali 190-215 parts, Myrrha 185-210 parts, Folium Artemisiae Argyi 80-105 parts, Herba Salviae Chinensiss 130-160 parts, Fructus Gardeniae 185-210 parts, Herba Asari 105-
130 parts, Fructus Gleditsiae Abnormalis 110-140 parts, Radix Paeoniae Alba 140-160 parts, Herba Paederiae 125-150 parts, Semen Cassiae 50-70 parts.
Its further preferred mass part proportioning is:Radix Et Rhizoma Rhei 180-205 parts, Concha Haliotidis 50-70 parts, toothed burclover 190-210 parts,
Radix Astragali 190-210 parts, Myrrha 190-210 parts, Folium Artemisiae Argyi 90-105 parts, Herba Salviae Chinensiss 140-160 parts, Fructus Gardeniae 190-210 parts, Herba Asari 110-
130 parts, Fructus Gleditsiae Abnormalis 120-140 parts, Radix Paeoniae Alba 145-160 parts, Herba Paederiae 130-150 parts, Semen Cassiae 50-70 parts.
Its further preferred mass part proportioning is:Radix Et Rhizoma Rhei 190-205 parts, Concha Haliotidis 55-70 parts, toothed burclover 190-205 parts,
Radix Astragali 195-210 parts, Myrrha 190-205 parts, Folium Artemisiae Argyi 95-105 parts, Herba Salviae Chinensiss 140-155 parts, Fructus Gardeniae 190-205 parts, Herba Asari 110-
125 parts, Fructus Gleditsiae Abnormalis 120-135 parts, Radix Paeoniae Alba 145-155 parts, Herba Paederiae 135-150 parts, Semen Cassiae 50-70 parts.
Its further preferred mass part proportioning is:Radix Et Rhizoma Rhei 190-200 parts, Concha Haliotidis 60-70 parts, toothed burclover 190-200 parts,
Radix Astragali 200-210 parts, Myrrha 190-200 parts, Folium Artemisiae Argyi 100-105 parts, Herba Salviae Chinensiss 150-155 parts, Fructus Gardeniae 200-205 parts, Herba Asari
110-120 parts, Fructus Gleditsiae Abnormalis 130-135 parts, Radix Paeoniae Alba 145-150 parts, Herba Paederiae 140-150 parts, Semen Cassiae 60-70 parts.
Its further preferred mass part proportioning is:200 parts of Radix Et Rhizoma Rhei, 60 parts of Concha Haliotidis, 200 parts of toothed burclover, 200 parts of the Radix Astragali,
200 parts of Myrrha, 100 parts of Folium Artemisiae Argyi, 150 parts of Herba Salviae Chinensiss, 200 parts of Fructus Gardeniae, 120 parts of Herba Asari, 130 parts of Fructus Gleditsiae Abnormalis, 150 parts of the Radix Paeoniae Alba, Herba Paederiae
140 parts, 60 parts of Semen Cassiae.
The primary raw material medicine that the present invention is used is described as follows:
Radix Et Rhizoma Rhei:Radix Et Rhizoma Rhei is being collectively referred to as the perennial plant of various Polygonaceae Rheums, and the title of Chinese crude drug.Radix Et Rhizoma Rhei of the present invention refers to
Be todaiwo,rhizoma.Autumn Mo stem and leaf is withered or the front excavation of secondary spring germination.Radicula is removed, crust, valve cutting or section is scraped off, rope wears bunchiness
It is dried or convection drying, Chinese herb rhubarb has attacks the effects such as stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, removing toxic substances.
Concha Haliotidis:For the shell of Bao Ke animal Haliotis diversicolors, haliotis discus hannai Ino, ear Bao, sheep Bao etc..Also known as natural pearls are female(《Thunder God big gun
Process opinion》), Carnis Haliotidiss first(《Collective Notes to Canon of Materia Medica》), nine hole spiral shells(《Japan hanako materia medica》), Herba Senecionis Scandentiss(《Detailed outline》), very sea certainly, Hai Jue
Bright, CONCHA HALIOTIDI, abalone shells, nine hole Concha Haliotidis(《Pharmacognosy》), Carnis Haliotidiss skin(《Shandong Chinese medicine handbook》), golden Carnis Mactrae skin(《In Shandong
Medical herbs》).There are calming liver and clearing heat, effect of shade removing.This product is conventional Chinese medicine, and " Mingyi Bielu " is classified as top grade.Modern commercially available product point
Determine for light bottom sea, hair bottom sea is certainly determined three kinds with sea.Original animal is determined for haliotis diversicolor Reeve in light bottom sea, and the extra large former animal of determining in hair bottom is big for disk
Bao, sea former animal certainly are sheep Bao.Other title natural pearls are female, Carnis Haliotidiss first, nine hole spiral shells, Herba Senecionis Scandentiss, Carnis Haliotidiss skin, golden Carnis Mactrae skin.
Toothed burclover:It is the address of the people to Herba Loti Tenuis on the ground such as Shanghai, granary, Changshu.Herba Loti Tenuis, original name south lucerne vegetables
MedicagohispidaGaertn has Ye Sanchi, such as reversed cardioid, tip slightly circle or recessed top to have sawtooth, and the surface of leaf is in dense
Green, stalk are extremely short, and main root is long, multi-branched.Stem is generally vertical, closely without hair, high 30-100 centimetre.Compound leaf has 3 lobules, lobule
Obovate or lanceolar, long 1-2 centimetre, wide about 0.5 centimetre, nose-circle, middle rib slightly protrude, and first half leaf has sawtooth, base portion
Narrow wedge shape;Stipule narrow lanceolar, full edge.Raceme axil is given birth to, flower 8-25.Pod spiral type, stingless, top has point to expose nozzle;
The production of two province of Jiangsu and Zhejiang Provinces is special more.Toothed burclover is leguminous plant, Jing often to eat toothed burclover element can balanced human pH-value.
The Radix Astragali:Also known as continuous stilbene.Perennial herb is high 50-100 centimetre.Main root is plump, wooden, normal branch, canescence.Stem
Uprightly, top multi-branched, has thin rib, by white pubescence.Perennial herb is high 50-100 centimetre.Originate in Inner Mongol, Shanxi, sweet
The ground such as respectful, Heilungkiang.The medicinal history for having more than 2000 years so far of the Radix Astragali, which has enhancing human body immunity function, liver protection, profit
Urine, defying age, anti-stress, blood pressure lowering and wide antibacterial action.But table excess pathogen contain, retention of dampness due to stagnation of QI, food stagnation stagnate, carbuncle from the beginning of
Or the excess syndrome such as pyretic toxicity Shang Sheng after bursting, and hyperactivity of YANG due to deficiency of YIN person, clothes must be prohibited.
Myrrha:Chinese medicine name, is olive subject plant Herba Violae tree CommiphoramyrrhaEngl. or Ha Didingshu
CommiphoramolmolEngl. dry resin.It is divided into natural Myrrha and gum opoponax.It is distributed in Somalia, Ethiopia Russia ratio
The ground such as sub- and Arabia Peninsula south.The effect of with scattered stasis pain, detumescence and promoting granulation.It is usually used in obstruction of qi in the chest and cardialgia, gastralgia, pain
The treatment of the diseases such as Jing amenorrhea, postpartum stagnation, abdominal mass stomachache, rheumatic arthralgia, traumatic injury, carbuncle swells sore.
Folium Artemisiae Argyi:Perennial herb or slightly into suffruticose, plant has enhanced aroma.Stem list is given birth to or minority, brown or sallow
Brown, base portion slightly lignifying, top Bi matter, and the branch for having minority short, leaf ground paper matter, above by canescence pubescence, base portion
Generally without pseudostipule or minimum pseudostipule;Upper leaf and bract leaf pinniform are partly split, head inflorescence ellipse, corolla tubulose or height
Foot cup-shaped, outside have gland point, and flower pesticide is narrow linear, and style and corolla be near isometric or slightly longer than corolla.Achene long avette or Long Circle.
The flowering fruit bearing stage 9-10 months.All herbal medicine, have warming the meridian, dry, cold expelling, hemostasis, antiinflammatory, relieving asthma, cough-relieving, the effect such as antiabortive, antiallergic.
Folium Artemisiae Argyi is dried and smashs to pieces " Folium Artemisiae Argyi ", and moxa roll processed can make the raw material of " ink paste " again for moxa-moxibustion.
Herba Salviae Chinensiss:Also known as:Dali Radix Rubiae, Rubiayunnanensis (Franch.) Dlels, Arisaema balansae Engl., dice piece etc., genus rubia mesh, Rubiaceae draft;Indication:
Heat-clearing and toxic substances removing, blood circulation promoting regulates qi pain relieving.Swell for acute, chronic hepatitis, gastral cavity side of body distending pain, damp-heat vaginal discharge, mastitis, furuncle.
Fructus Gardeniae:Another name Yellow Fructus Gardeniae, Fructus Gardeniae, white toad, Flos Gardeniae, are the fruits of Maguireothamnus speciosus Fructus Gardeniae.Genus rubia section, Fructus Gardeniae
Category, evergreen shrubss;Root, leaf, fruit can be used as medicine, and have the effect of purging intense heat relieving restlessness, clearing away heat and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body;Effect:Clearly
Lung cough-relieving, cooling blood for hemostasis, pathogenic fire purging cure mainly cough due to lung-heat, cough up phlegm, toxic swelling, control calentura restlessness of asrhenia type and insomnia, and jaundice, gonorrhea are quenched one's thirst, mesh
Red, pharyngalgia is spitted blood, and epistaxis, dysentery, hematuria, pathopyretic ulcer are sprained and swollen and ache.《Dictionary of medicinal plant》Described in:Fructus Gardeniae, different name:Wood
Red (《This Jing》), fresh (《Upper woods is assigned》), ancient wine vessel (《Chinese book》Meng Kang note), more Fructus Persicae (《Do not record》), stand (《Collective Notes to Canon of Materia Medica》),
SHANZHIZI (《Haigoushen》), Fructus Gardeniae (《Newly Revised Canon of Materia Medica》), it is little danger son (《Book on Chinese herbal medicine is original》), Huang sprout (《Fujian east book on Chinese herbal medicine》), yellow Cape jasmine
Son (《Jiangsu medical material will》), yellow Cape jasmine, gardenia jasminoides ellis, Fructus Gardeniae (《Zhejiang medicinal plants will》);For Rubiaceae Fructus Gardeniae platymiscium Fructus Gardeniae
Fruit.
Herba Asari;Another name:Asarum sieboldii, basin grass Herba Asari, Aristolochiaceae, asarum perennial herb;Herba Asari as medicinal plants,
Shi Zai Qin Han《Sheng Nong's herbal classic》,《Sheng Nong's herbal classic》It is classified as top grade.Herba Asari root is thin, color sallow, leaf color are green, and acrid in the mouth is peppery
Numb tongue.It is warm in nature, it is slightly poisonous.GUIXIN, lung, kidney channel.There are wind-dispelling, cold expelling, warming the lung, water-filling, the effect having one's ideas straightened out.Control headche due to wind-cold, nose
Deep pool, toothache, phlegm retention cough with dyspnea, rheumatic arthralgia.Additionally, Herba Asari also have anti inflammatory immunity, Herba Asari local anesthesia, improve metabolism,
Antibacterial action, also can be used for the leukopenia of Chemotherapy of Tumor Patients and caused by radiation.
Fructus Gleditsiae Abnormalis:Also known as:Fructus Gleditsiae Abnormalis.It is the small-sized fruit tied after leguminous plant Fructus Gleditsia plant injury, bends to crescent.
The flat elder of shape, referred to as big Fructus Gleditsia(That is Fructus Gleditsia).Containing triterpenoid saponin, tannin, ceryl alcohol, nonacosane, stigmasterol etc..There is eliminating the phlegm, urge
Tell, the effect such as diarrhea inducing.
The Radix Paeoniae Alba:Also referred to as Paeonia sterniana Fletcher in Journ., is Ranunculaceae Radix Paeoniae platymiscium.In the existing long cultivation history of China, in being renown far and wide
Outward, which claims Paeonia sterniana Fletcher in Journ..Its root can be used as medicine.Smooth liver and relieve pain, nourishing blood for regulating menstruation, astringing YIN to stop sweating.For dizziness of having a headache, hypochondriac pain, suffer from abdominal pain,
Limb pain twin, blood deficiency and yellow complexion, menoxenia, spontaneous perspiration, night sweat.
Herba Paederiae:Herba Paederiae refers generally to fevervine, is the herb of Maguireothamnus speciosus fevervine, summer harvesting herb, dries.
Its sweet in the mouth, slight bitter, it is mild-natured.The effect of with expelling wind and removing dampness, analgesic antidotal, promoting digestion and removing stagnation, promoting blood circulation and detumescence.For rheumatism muscles and bones
Bitterly, traumatic injury, traumatic pain, liver and gall and stomach intestinal colic, dyspepsia, infantile malnutrition, bronchitis;It is used for outward dermatitis,
Eczema and sore swollen toxin.
Semen Cassiae:The dry mature seed of leguminous plant Semen Cassiae or little Cassia tora, with its have improving eyesight work(and name it.Autumn
Harvesting mature fruit, dries, and lays seed, removes impurity.Semen Cassiae bitter in the mouth, sweet, salty, cold nature, enter liver, kidney, large intestine channel;Profit
Intestinal relieving constipation, lipid-loweringing improving eyesight, treatment constipation and hyperlipidemia, hypertension.Liver heat removing and eyesight improving, diuretic relieving constipation have laxative action, blood pressure lowering drop
Blood fat.
In the medicine of the present invention there is no incompatibility in each material combination, can substantially reduce the generation of Rana grylia disease
Rate, has good preventive and therapeutic action to Rana grylia disease, and has no toxic side effect, using safety, residual without hazardous drugs
Stay.
It is a further object of the present invention to provide a kind of preparation method of said medicine, its process is simple, its crude drug is common,
Cheaply.
The preparation method of medicine of the present invention is as follows:
The first step:The raw material weight of batch production is calculated by formula proportion;
Second step:The raw material for calculating batch production is positioned in stirring container, be soaked in water 3-5 hours, wherein the use of water
Measure 30 times for Chinese medicine gross weight;Warm fire heating is burnt to seething with excitement, and endures 15-20 minutes, and after being then incubated 3 hours, then warm fire heating is burnt
To seething with excitement, 25-30 minutes are endured;
3rd step:Carry out centrifugal filtration, filtrate after 2-3 hours precipitation, second centrifugal filtration;Filtrate is this
The medicine of bright preventing and treating Rana grylia disease.
The medicine using method of the present invention:Into the frog phase, when feeding every time, every 10 kg diet weighs 1000 grams of U.S. green grass or young crops
The protective agents filtrate of frog disease, adds 50 grams of brown sugar in Chinese medicine composition filtrate, is subsequently adding in feedstuff, mixes,
Feed immediately, sooner or later each daily to feed once, free choice feeding, 10 days is a course for the treatment of, can feed this medicine one every 10 days
The individual course for the treatment of, froglet phase medicine halve.
In order to be illustrated more clearly that the present invention, following examples are enumerated, but its scope to invention is without any restrictions.
Specific embodiment
Embodiment 1
Weigh Radix Et Rhizoma Rhei 200g, Concha Haliotidis 60g, toothed burclover 200g, Radix Astragali 200g, Myrrha 200g, Folium Artemisiae Argyi 100g, Herba Salviae Chinensiss 150g, Fructus Gardeniae
200g, Herba Asari 120g, Fructus Gleditsiae Abnormalis 130g, Radix Paeoniae Alba 150g, Herba Paederiae 140g, 60 parts of Semen Cassiae, these material compositions are through shining
Quality after dry;
The first step:The raw material weight of batch production is calculated by formula proportion;
Second step:The raw material for calculating batch production is positioned in stirring container, is soaked in water 4 hours, wherein the consumption of water
For 30 times of Chinese medicine gross weight;Warm fire heating is burnt to boiling, endures 20 minutes, and after being then incubated 3 hours, then warm fire heating is burnt to boiling
Rise, endure 30 minutes;
3rd step:Carry out centrifugal filtration, filtrate after 2 hours precipitations, second centrifugal filtration;Filtrate is the present invention
The medicine of preventing and treating Rana grylia disease.
Embodiment 2-14
Embodiment 2-12 in addition to raw material mass mixture ratio is different from embodiment 1, its raw material type and step of preparation process and use
Method is same as Example 1, and comparative example 1 is that Myrrha is eliminated on the basis of embodiment 1, and comparative example 2 is the base in embodiment 1
Herba Salviae Chinensiss are eliminated on plinth, raw material that embodiment 1-12, comparative example 1-2 are used and quality as shown in Table 1 below, table below
1 shows the raw material and quality used by embodiment 1-12, comparative example 1-2.
Table 1
Clinical trial one:
(1) laboratory animal
Select 300 Rana grylias with torticollis disease into the frog, loss of appetite, be reluctant activity;
(2) experimental technique
It is random to be grouped, 15 groups are divided into, 20 per group, wherein 14 groups is experimental group, embodiment 1-12, comparative example 1- is fed respectively
The feedstuff that medicine described in 2 is made into, daily 2 times, free choice feeding, continuous 10 days;Another group is matched group, using prior art sulfanilamide
Pyrimidine therapy, feeds according still further to normal feed mode.Treatment is observed and is made a record, be specifically shown in Table 2 for 10 days afterwards;
(3) standard and observational technique are treated
Cure:Torticollis disease recovery from illness;
Effectively:Torticollis disease is effectively alleviated, and has very big alleviation;
It is invalid:Torticollis disease is not effectively alleviated.
Table 2
Cure number | Significant figure | Invalid number | |
Embodiment 1 | 20 | 0 | 0 |
Embodiment 2 | 19 | 1 | 0 |
Embodiment 3 | 20 | 0 | 0 |
Embodiment 4 | 19 | 1 | 0 |
Embodiment 5 | 19 | 1 | 0 |
Embodiment 6 | 18 | 1 | 1 |
Embodiment 7 | 19 | 1 | 0 |
Embodiment 8 | 18 | 1 | 1 |
Embodiment 9 | 19 | 1 | 0 |
Embodiment 10 | 19 | 1 | 0 |
Embodiment 11 | 20 | 0 | 0 |
Embodiment 12 | 19 | 1 | 0 |
Comparative example 1 | 12 | 5 | 3 |
Comparative example 2 | 12 | 5 | 3 |
Matched group | 10 | 2 | 8 |
It follows that in the case of equal consumption, it is right that the therapeutic effect being mixed into using medicine of the present invention in feedstuff is substantially better than
Ratio and matched group.And after 1 month, experimental group is 0 recurrence, and matched group has 4 recurrences.
Clinical trial two:
In order to prove feeding effect of the present invention to Rana grylia, feeding experiment is repeatedly tried, choose large-scale Rana grylia and support
Field 3000 is grown in the Rana grylia into the frog phase, body weight size, health status are basically identical, are randomly divided into 15 groups, per group 200
Only.Wherein 14 groups is experimental group, the feedstuff that feeding embodiment 1-12, medicine described in comparative example 1-2 are made into respectively, twice daily,
Free choice feeding, continuous 10 days;One course for the treatment of of this medicine was fed every 10 days.Another group is matched group, feeds and is not added with the identical of medicine
Feedstuff, the nursing number of times of 15 groups of Rana nigromaculatas, feeding volume, nursing time all same.The various performance indications of 15 groups of Rana nigromaculatas are contrasted, averagely
Value such as table 3.
After 1 month, 15 groups of Rana nigromaculata situation such as tables 3:
Table 3
Ill evil number | Moon weightening (g)/only | |
Embodiment 1 | 0 | 135 |
Embodiment 2 | 1 | 127 |
Embodiment 3 | 0 | 129 |
Embodiment 4 | 0 | 129 |
Embodiment 5 | 0 | 137 |
Embodiment 6 | 0 | 139 |
Embodiment 7 | 0 | 129 |
Embodiment 8 | 0 | 129 |
Embodiment 9 | 3 | 128 |
Embodiment 10 | 0 | 136 |
Embodiment 11 | 0 | 130 |
Embodiment 12 | 0 | 132 |
Comparative example 1 | 30 | 118 |
Comparative example 2 | 40 | 110 |
Matched group | 100 | 90 |
Can be evident that from table, after the medicine that the continuous feeding present invention is provided, daily gain is more right for experimental group Rana nigromaculata
Increase obvious according to group, and experimental group is compared with matched group honey stomach, energetic, state is good, substantially no disease occurs.
So the present invention is not limited to the protective agents as Rana grylia disease, as long as composition of raw materials and phase of the present invention
Same or equivalent medicine just falls within the scope and spirit of the invention.By the protective agents with the Rana grylia disease of the present invention
The raw material of same recipe is made any Chinese medicine preparation and is also fallen within the scope and spirit of the invention, if that is, composition of raw materials with
Identical medicine of the present invention just falls within the scope and spirit of the invention.
Claims (7)
1. a kind of protective agents of Rana grylia disease, it is characterised in that be made up of the crude drug of following masses part proportioning:Radix Et Rhizoma Rhei
170-210 parts, Concha Haliotidis 50-80 parts, toothed burclover 190-220 parts, Radix Astragali 180-215 parts, Myrrha 180-210 parts, Folium Artemisiae Argyi 80-110
Part, Herba Salviae Chinensiss 130-165 parts, Fructus Gardeniae 185-215 parts, Herba Asari 105-135 parts, Fructus Gleditsiae Abnormalis 105-140 parts, Radix Paeoniae Alba 135-160 parts, chicken droppings
Rattan 120-150 parts, Semen Cassiae 50-70 parts.
2. protective agents of Rana grylia disease according to claim 1, it is characterised in that Radix Et Rhizoma Rhei 170-205 parts, Concha Haliotidis
Bright 50-75 parts, toothed burclover 190-215 parts, Radix Astragali 190-215 parts, Myrrha 185-210 parts, Folium Artemisiae Argyi 80-105 parts, Herba Salviae Chinensiss 130-160
Part, Fructus Gardeniae 185-210 parts, Herba Asari 105-130 parts, Fructus Gleditsiae Abnormalis 110-140 parts, Radix Paeoniae Alba 140-160 parts, Herba Paederiae 125-150 parts, certainly
Pine torch 50-70 parts.
3. protective agents of Rana grylia disease according to claim 1, it is characterised in that Radix Et Rhizoma Rhei 180-205 parts, Concha Haliotidis
Bright 50-70 parts, toothed burclover 190-210 parts, Radix Astragali 190-210 parts, Myrrha 190-210 parts, Folium Artemisiae Argyi 90-105 parts, Herba Salviae Chinensiss 140-160
Part, Fructus Gardeniae 190-210 parts, Herba Asari 110-130 parts, Fructus Gleditsiae Abnormalis 120-140 parts, Radix Paeoniae Alba 145-160 parts, Herba Paederiae 130-150 parts, certainly
Pine torch 50-70 parts.
4. protective agents of Rana grylia disease according to claim 1, it is characterised in that Radix Et Rhizoma Rhei 190-205 parts, Concha Haliotidis
Bright 55-70 parts, toothed burclover 190-205 parts, Radix Astragali 195-210 parts, Myrrha 190-205 parts, Folium Artemisiae Argyi 95-105 parts, Herba Salviae Chinensiss 140-155
Part, Fructus Gardeniae 190-205 parts, Herba Asari 110-125 parts, Fructus Gleditsiae Abnormalis 120-135 parts, Radix Paeoniae Alba 145-155 parts, Herba Paederiae 135-150 parts, certainly
Pine torch 50-70 parts.
5. protective agents of Rana grylia disease according to claim 1, it is characterised in that Radix Et Rhizoma Rhei 190-200 parts, Concha Haliotidis
Bright 60-70 parts, toothed burclover 190-200 parts, Radix Astragali 200-210 parts, Myrrha 190-200 parts, Folium Artemisiae Argyi 100-105 parts, Herba Salviae Chinensiss 150-155
Part, Fructus Gardeniae 200-205 parts, Herba Asari 110-120 parts, Fructus Gleditsiae Abnormalis 130-135 parts, Radix Paeoniae Alba 145-150 parts, Herba Paederiae 140-150 parts, certainly
Pine torch 60-70 parts.
6. protective agents of Rana grylia disease according to claim 1, it is characterised in that 200 parts of Radix Et Rhizoma Rhei, Concha Haliotidis 60
Part, 200 parts of toothed burclover, 200 parts of the Radix Astragali, 200 parts of Myrrha, 100 parts of Folium Artemisiae Argyi, 150 parts of Herba Salviae Chinensiss, 200 parts of Fructus Gardeniae, 120 parts of Herba Asari, Fructus Gleditsiae Abnormalis
130 parts, 150 parts of the Radix Paeoniae Alba, 140 parts of Herba Paederiae, 60 parts of Semen Cassiae.
7. the preparation method of the protective agents of Rana grylia disease according to claim 1, it is characterised in that including following step
Suddenly:
The first step:The raw material weight of batch production is calculated by formula proportion;
Second step:The raw material for calculating batch production is positioned in stirring container, be soaked in water 3-5 hours, wherein the use of water
Measure 30 times for Chinese medicine gross weight;Warm fire heating is burnt to seething with excitement, and endures 15-20 minutes, and after being then incubated 3 hours, then warm fire heating is burnt
To seething with excitement, 25-30 minutes are endured;
3rd step:Carry out centrifugal filtration, filtrate after 2-3 hours precipitation, second centrifugal filtration;Filtrate is as prevented and treated
The medicine of Rana grylia disease.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611110762.2A CN106511547A (en) | 2016-12-06 | 2016-12-06 | Medicine for preventing and treating frog disease in America and preparation method of medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611110762.2A CN106511547A (en) | 2016-12-06 | 2016-12-06 | Medicine for preventing and treating frog disease in America and preparation method of medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106511547A true CN106511547A (en) | 2017-03-22 |
Family
ID=58341605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611110762.2A Pending CN106511547A (en) | 2016-12-06 | 2016-12-06 | Medicine for preventing and treating frog disease in America and preparation method of medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106511547A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107854521A (en) * | 2017-11-27 | 2018-03-30 | 衡阳市日升娃娃鱼养殖基地 | Prevent and treat medicine of giant salamander abdominal distension disease and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105232704A (en) * | 2015-11-15 | 2016-01-13 | 衡阳市金凤牲猪养殖专业合作社 | Medicine for preventing and treating bovine rumen flatulence and preparation method thereof |
-
2016
- 2016-12-06 CN CN201611110762.2A patent/CN106511547A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105232704A (en) * | 2015-11-15 | 2016-01-13 | 衡阳市金凤牲猪养殖专业合作社 | Medicine for preventing and treating bovine rumen flatulence and preparation method thereof |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107854521A (en) * | 2017-11-27 | 2018-03-30 | 衡阳市日升娃娃鱼养殖基地 | Prevent and treat medicine of giant salamander abdominal distension disease and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107303383A (en) | A kind of Chinese medicine composition and its derivative and product to a variety of symptoms with effect | |
CN105232704A (en) | Medicine for preventing and treating bovine rumen flatulence and preparation method thereof | |
CN105287841A (en) | Drug for preventing swine erysipelas and preparation method thereof | |
CN106421025A (en) | Medicine composition for preventing and treating red leg-diseases of American frogs | |
CN104056138A (en) | Traditional Chinese medicine for treating simple goiter and preparation method of traditional Chinese medicine | |
CN106474230A (en) | Chinese medicine composition of preventing and treating Rana grylia torticollis disease and preparation method thereof | |
CN110064017A (en) | A kind of Chinese medicine composition and preparation method preventing and treating cardiovascular and cerebrovascular disease | |
CN106511547A (en) | Medicine for preventing and treating frog disease in America and preparation method of medicine | |
CN106474229A (en) | A kind of protective agents of Rana grylia torticollis disease and preparation method thereof | |
CN105876159A (en) | Additive for improving meat quality of Coilia ectenes and preparation method thereof | |
CN106421024A (en) | Traditional Chinese medicine composition for prevention and control of rana grylio diseases and preparation method of traditional Chinese medicine composition for prevention and control of rana grylio diseases | |
CN104873730A (en) | Traditional Chinese medicine for treating acute mastitis with liver-qi stagnancy | |
CN111228414A (en) | Health food or Chinese herbal compound for improving male sexual function and ultrasonic preparation method | |
CN109646665A (en) | Cortex Eucommiae clearing lung-heat anticancer solid tea and preparation method thereof | |
CN109528984A (en) | A kind of cream formula and preparation method by smearing breast treatment mammary gland disease | |
CN108324916A (en) | Treat the Chinese medicine and preparation method thereof of tumour | |
CN106491768A (en) | Chinese medicine composition of preventing and treating Rana grylia red leg disease and preparation method thereof | |
CN114984147B (en) | Tea capable of warming interior and dispelling cold and preparation method thereof | |
CN106474224A (en) | A kind of protective agents of Rana grylia red leg disease and preparation method thereof | |
CN115998828B (en) | Traditional Chinese medicine composition for treating hyperplasia of mammary glands and preparation method thereof | |
CN106490092A (en) | A kind of coffee flavor health cake and manufacture method | |
Ye et al. | Medicinal Angiosperms of Iridaceae, Stemonaceae, Dioscoreaceae, Agavaceae, Palmae, Pandanaceae, and Hypoxidaceae | |
CN107744544A (en) | Prevent and treat Chinese medicine composition of doll's red skin and preparation method thereof | |
CN105815592A (en) | Chinese herbal medicine chicken feed additive | |
CN107648352A (en) | A kind of Chinese medicine extract for treating doll's red skin and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170322 |